Press "Enter" to skip to content

Novartis’ cancer treatment Kymriah gets Japan nod at cost of $305,800

A Japanese government panel approved Novartis’ cancer treatment Kymriah at a price of 33.5 million yen ($305,800) on Wednesday, marking the entry of so-called CAR-T therapy in the country.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/nl1hVgx_x3c/novartis-cancer-treatment-kymriah-gets-japan-nod-at-cost-of-305800-idINKCN1SL057

Also Read:   U.S. jury to determine liability, damages in Roundup cancer trial